[ad_1] (Reuters) – Health insurer Cigna Corp on Wednesday launched a program aimed at ensuring some diabetes patients pay no more than $25 for a 30-day supply of insulin in the wake of heightened public
Cigna launches program to cap out-of-pocket insulin costs at $25/month
